CDSCO Advisory May 2026 India's CDSCO issued a public notice on May 18, 2026 placing injectable glutathione drips under regulatory scrutiny
These abnormalities were previously regarded as secondary epiphenomena of metabolic dysfunction, but accumulating evidence now indicates that they arise from hyperglycaemia-driven OCTN2 impairment, insulin resistance, and oxidative stress, together forming a distinct carnitine-related metabolic signature
More importantly, the athletes on Salazars Nike Oregon Project team werent always positive about what medications were being given, and how much
A pragmatic approach is to discontinue semaglutide (35 days) or tirzepatide (2535 days) before conception and liraglutide 3 days prior, transition to safer alternatives such as metformin, and recommend enhanced fetal monitoring in cases of inadvertent exposure
Some people should not take GLP-1 prescriptions
Although melanoma can develop from a common mole, it is uncommon for it to do so
